A mutation inNOTCH2gene first associated with Hajdu-Cheney syndrome in a Greek family: diversity in phenotype and response to treatment

Introduction Hajdu-Cheney Syndrome (HCS) is a rare genetic autosomal dominant disorder, characterized by distinctive facial features, acroosteolysis, and severe osteoporosis. Very rarely HCS is associated with polycystic kidney disease, splenomegaly or Crohn's disease (CD). It is caused by gain-of-function mutations inNOTCH2gene. Treatment with bisphosphonates or denosumab is reported to result in BMD increase. Objective We report a mutation in exon 34 ofNOTCH2gene, in a Greek pedigree, with diverse phenotypes among members. Description of the pedigree The 48-year-old mother had a history of a T12 vertebral fracture, postpartum at the age of 21 and two subsequent uneventful full-term pregnancies and never received treatment. Her 29-year-old son, presented with severe osteoporosis and multiple morphological vertebral fractures. Her 21-year-old daughter had recurrent vertebral fractures starting at 10 years of age. At 17 years, she developed severe CD, resistant to treatment with biologic agents, and functional hypothalamic hypogonadism. One male pedigree died of cystic fibrosis. All subjects bore the typical facial characteristics and acroosteolysis, while none had splenomegaly or renal defects. Zoledronate infusion led to BMD increase. Genetic testing Mutation in c.6758 G > A (NM_008163.1), leading to a Trp2253Ter replacement. This mutation has been reported as possibly pathogenic (SCV000620308), but not in association with HCS. Conclusions Bone involvement can present with diverse severity in the same pedigree, ranging from low BMD to multiple fragility fractures. Antiresorptive therapy improves BMD, but its anti-fracture efficacy remains to be shown. The presence of CD might indicate the significant role of NOTCH2 signaling in different tissues.

Automated summary

Hajdu-Cheney Syndrome (HCS) is a rare genetic disorder characterized by distinctive facial features, acroosteolysis, and severe osteoporosis. In a Greek pedigree, diverse phenotypes were observed among family members, including fractures and Crohn's disease. The mutation in NOTCH2 gene may play a significant role in bone involvement and development of associated conditions.